About Aortica Corp
Aortica Corp is a Healthcare company based in Bellevue (United States) founded in 2014, and was acquired by Terumo Medical in November 2019. Endovascular aortic repair using 3D medical printing techniques is developed. Aortica Corp has raised $7 million across 1 funding round from investors including Terumo Medical. The company has 2 employees. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is AORTICA CORPORATION. Its competitors include Endologix, Trivascular and Altura Medical; 2 of its 3 listed competitors have raised funding.
Company details
Aortica Corporation was founded in 2014 and is headquartered in Bellevue, United States. Technology is developed to address abdominal aortic aneurysm disease through endovascular methods. Stent grafts are delivered via catheter insertion into the aorta, supported by 3D medical printing processes. Operations center on cardiovascular medical devices, with a focus on procedural tools for physicians in the healthcare sector.
- Headquarters Bellevue, United States
- Employees 2
- Stage Acquired
- SectorsHealthcare
- Website aorticacorp.com
- Acquired by Terumo Medical (Nov 2019)
- Legal Name Aortica Corporation
- Total Equity Funding$7M (USD)
in 1 rounds
- Latest Funding Round$7M (USD), Series A
Nov 2014
- Investors
- Employee Count2
- Acquired byTerumo Medical
(Nov 2019)
Funding Insights of Aortica Corp
Aortica Corp has successfully raised a total of $7M through 1 strategic funding round. The most recent funding activity was a Series A round of $7 million completed in November 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7M
- Total Rounds 1
- Last Round Series A — $7M
- First Round $7M
(Nov 2014)
All 1 funding rounds of Aortica Corp with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2014 | $7M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Aortica Corp
Aortica Corp has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Terumo Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Portfolio of medical devices for interventional cardiology is provided. | 1921 | terumo.com | Somerset, United States |
Investor details for Aortica Corp
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Aortica Corp
3 dated milestones of Aortica Corp across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Aortica Corp is founded.
- Funding First funding round of $7.0M.
- Exit Acquired by Terumo Medical.
Competitors of Aortica Corp
Aortica Corp has 3 listed competitors in our database, 2 of them funded. They include Endologix, Trivascular and Altura Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endologix.com | 1992 | Irvine, United States | 488 | Minimally invasive treatments for aortic disorders are developed and manufactured. | ||
| trivascular.com | 1998 | Santa Rosa, United States | $260.95M | 307 | Designs and manufactures for endovascular aortic repair equipment | |
| alturamedical.com | 2008 | Menlo Park, United States | $49.5M | Endovascular devices for aortic aneurysms are developed. |
Detailed competitors of Aortica Corp
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Aortica Corp (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aortica Corp
Complete news archive for Aortica Corp
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aortica Corp
Aortica Corp was founded in 2014.
Aortica Corp is headquartered in Bellevue, United States. It is registered at Bellevue, Washington, United States.
Aortica Corp is a funded company, having raised a total of $7M across 1 funding round to date. The company's 1st funding round was a Series A of $7M, raised on Nov 2014.
Aortica Corp has 2 employees.
Aortica Corporation was founded in 2014 and is headquartered in Bellevue, United States. Technology is developed to address abdominal aortic aneurysm disease through endovascular methods. Stent grafts are delivered via catheter insertion into the aorta, supported by 3D medical printing processes. Operations center on cardiovascular medical devices, with a focus on procedural tools for physicians in the healthcare sector.
Aortica Corp's top competitors include Endologix, Trivascular and Altura Medical.
Aortica Corp has 1 investor. Key investors include Terumo Medical.
Aortica Corp operates through Aortica Corporation.
Yes. Aortica Corp was acquired by Terumo Medical in November 2019.